Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ESCITALOPRAM OXALATE Cause Hyperammonaemia? 9 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Hyperammonaemia have been filed in association with ESCITALOPRAM OXALATE (Escitalopram). This represents 0.0% of all adverse event reports for ESCITALOPRAM OXALATE.

9
Reports of Hyperammonaemia with ESCITALOPRAM OXALATE
0.0%
of all ESCITALOPRAM OXALATE reports
0
Deaths
7
Hospitalizations

How Dangerous Is Hyperammonaemia From ESCITALOPRAM OXALATE?

Of the 9 reports, 7 (77.8%) required hospitalization, and 3 (33.3%) were considered life-threatening.

Is Hyperammonaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ESCITALOPRAM OXALATE. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does ESCITALOPRAM OXALATE Cause?

Drug ineffective (2,792) Anxiety (1,686) Headache (1,643) Somnolence (1,640) Nausea (1,635) Completed suicide (1,504) Drug interaction (1,477) Toxicity to various agents (1,446) Fatigue (1,443) Off label use (1,422)

What Other Drugs Cause Hyperammonaemia?

VALPROIC ACID (581) VALPROATE (328) FLUOROURACIL (263) DIVALPROEX (256) LEVETIRACETAM (192) TACROLIMUS (181) ACETAMINOPHEN (177) OXALIPLATIN (160) TOPIRAMATE (156) GLYCEROL PHENYLBUTYRATE (147)

Which ESCITALOPRAM OXALATE Alternatives Have Lower Hyperammonaemia Risk?

ESCITALOPRAM OXALATE vs ESKETAMINE ESCITALOPRAM OXALATE vs ESLICARBAZEPINE ESCITALOPRAM OXALATE vs ESMOLOL ESCITALOPRAM OXALATE vs ESOMEPRAZOLE ESCITALOPRAM OXALATE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE

Related Pages

ESCITALOPRAM OXALATE Full Profile All Hyperammonaemia Reports All Drugs Causing Hyperammonaemia ESCITALOPRAM OXALATE Demographics